Scientists in the UK are hailing trials for the development of an mRNA vaccine used to treat patients with skin cancer. Host Carol Hills speaks with Dr. Lawrence Young, professor of Molecular Oncology at the University of Warwick, about how the vaccine works and other potential benefits.
This content was originally published here.
